• Avandia®
• Avandia® Death Risk
• Avandia® Heart Attack
• Avandia® Pph
• Congestive Heart Failure
• Dangers of Avandia®
• Avandia® Diabetes
• Avandia® Recall
• Avandia® Side Effects
• Avandia® Information
• Avandia® Attorneys
• Avandia® Lawyers
• Avandia® Lawsuit
• Avandia® Class Action Lawsuits
• Avandia® Litigations
• Avandia® Settlements
• Avandia® Overdose
• Avandia® & Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Avandia®, an oral medication used to treat type-2 diabetes, has been found to increase the chances that individuals taking this drug will develop severe, potentially life-threatening side effects. To date, the Food and Drug Administration (FDA) has not issued a formal recall on Avandia®.

However, in August 2008, a medical journal entitled Heart published a study that:

• highlighted the dangers thiazolidinediones (the class of drugs to which Avandia® belongs)
• urged the FDA to place stricter restrictions on use of Avandia® (and similar medications)
• questioned why an Avandia® recall had not yet been issued

In response to this research, the FDA mandated that GlaxoSmithKline (the maker of Avandia®) include “black box” warnings on all Avandia® packaging. Black box warnings are the most serious warnings issued by the FDA, as they indicate that a drug has the potential to cause severe injury, permanent disability and/or death.

Following this mandate, the FDA voted 8 to 7 against issuing an Avandia® recall.

Avandia® Side Effects & Recall

Some of the serious injuries associated with Avandia® use (and used as a basis of urging an Avandia® drug recall) include:

• bone fracture (especially in the arms, hands or feet)
• congestive heart failure (CHF)
• heart attack (Studies show that diabetic patients taking Avandia® are up to 40 percent more likely to sustain a heart attack.)
• hypoglycemia (dangerously low blood sugar)
• hyperglycemia (dangerously high blood sugar)
• jaundice
• liver dysfunction
• severe allergic reaction
• upper respiratory tract infection

Without treatment, some of these side effects – particularly heart attack, CHF and severe allergic reaction – can be fatal.

Avandia® patients with the highest risk of sustaining these side effects include those with a history of:

• CHF
• eye problems related to diabetes
• heart attack
• liver disease
• stroke

Additionally, diabetic patients who do NOT eat healthfully and do NOT exercise regularly will also have a greater risk of developing severe Avandia® side effects.

Avandia® Recall Lawyers

Patients who sustain serious side effects after taking Avandia® should:

• Receive emergency medical attention to prevent further injury and, in the worst cases, save their lives
• Follow through with all long-term prescribed care for the best chances of recovery
• Work with their doctor to find a suitable alternative to Avandia® diabetes medication
• Consult with an experienced defective drug attorney, once their health is stable, to find out if they have a case against GlaxoSmithKline

To encourage injured Avandia® patients to learn more about their legal rights and entitlements, Avandia® lawyers:

• Offer initial consultations for free and with no obligation
• Will delay payment for legal services until (or unless) the case is settled

For more information about Avandia® recall and other defective drugs, please contact an Avandia® lawyer today.

"FDA Announces Avandia® Label Change"

The FDA announced that is has made a change regarding cardiovascular risks to the Avandia® (rosiglitazone) label and patient Medication Guide, Feb. 4, 2011.

The FDA announcement also said that Avandia®'s drug label was updated ...

» Read More

"Risk of Death Halts Government Study"

A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.

The 10,000 patient trial was examining the effectiveness of aggressive ...

» Read More

"Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avan"

A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.

Ob...

» Read More